United Therapeutics (NASDAQ:UTHR) CEO Martine A. Rothblatt sold 9,662 shares of the firm’s stock in a transaction on Thursday, August 27th. The stock was sold at an average price of $160.37, for a total …
Ticker Report · 17 hours ago
United Therapeutics
A study of analyst recommendations at the major brokerages shows that United Therapeutics Corp (UTHR) is the #87 broker analyst pick among those stocks screened by The Online Investor for strong stock buyback …
The Street · 8/21/2015
Buyback Activity
The stock currently has an average rating of Hold and a consensus price target of $159.93. United Therapeutics (NASDAQ:UTHR) opened at 162.66 on Monday. United Therapeutics has a 1-year low of $90.40 and a …
Mideast Times · 8/21/2015
More from Bing News
United Therapeutics (NASDAQ:UTHR)‘s stock had its “outperform” rating restated by equities researchers at Cowen and Company in a research report issued on Monday, MarketBeat.Com reports. They presently have a $185.00 price target on the … · 8/19/2015
Tree.Com (NASDAQ: TREE) – Patel Nikul sold 1,000 stocks at $109.28. United Therapeutics Corp. (NASDAQ: UTHR) – Rothblatt Martine A sold 2,592 stocks at $154.86. Vascular Solutions (NASDAQ: VASC) – …
Fx Pips · 8/26/2015
Big biotech United Therapeutics (NASDAQ:UTHR) agreed to sell its priority-review voucher to ... MRK), among others. Drug stocks in general were down along with the rest of the market early on the stock market today.
Investors Business Daily · ByAmy Reeves · 8/18/2015
United Therapeutics
Among the companies with shares expected to trade actively in Wednesday's session Staples Inc. ( SPLS), United Therapeutics Corp. ( UTHR), and Lowe's Cos. ( LOW). Staples Inc. said its profit more than halved in the second quarter, as sales continued …
NASDAQ · 8/19/2015
Hot Stocks
The consideration represents a 50% premium over the preceding three month stock price average ... United Therapeutics (N: UTHR) has entered into an agreement to sell its Rare Pediatric Disease Priority Review …
StreetInsider · 8/19/2015
Healthcare stocks finished up 0.6% on Wall Street today. More broadly, the Dow Jones Industrial Average declined 0.2%, the Nasdaq was down 0.1% and the S&P 500 fell 0.2%. Some of the biggest gainers among healthcare stocks include: Theravance …
Investor Place · 7/31/2015
Rothblatt, Chairman & Co-CEO at United Therapeutics Corporation (NASDAQ:UTHR) sold 9,662 shares at $160.37 ... Editor's Note: This article covers one or more stocks trading at less than $1 per share and/or with less than a $100 million market cap.
Seeking Alpha · 22 hours ago